Clinical trial

Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance

NCT07122882

StatusENROLLING_BY_INVITATION

Study typeOBSERVATIONAL

Start date2025-09-01

PhaseN/A

Study timeline

Study start (actual)2025-09-01Date precision: day

Registry last updated2026-03-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Oncogene-addicted Non Small Cell Lung Cancerunresolved

EGFR Mutationunresolved

ALK Fusion-positive Solid or CNS Tumorsunresolved

ROS1 Fusion Positiveunresolved

RET Fusion Positiveunresolved

ERBB2 Mutation-Related Tumorsunresolved

NTRK1 Fusion Positiveunresolved

NTRK2 Fusion Positiveunresolved

NTRK3 Fusion Positiveunresolved

NRG1 Fusionunresolved

BRAF V600 Mutationunresolved

KRAS G12C Mutationunresolved

MET Exon 14 Skipping Mutationunresolved

Interventions

Sponsors & collaborators

Chang Gung Memorial Hospitallead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07122882 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.